Clinical efficacy and randomized clinical trials in dysphagia

Abstract This manuscript reviews the current state of research on treatment efficacy for swallowing disorders in relation to the use of large-scale randomized multi institutional trials. Dose response trials, i.e., how much treatment is needed to achieve the desired result, are not yet available in...

Full description

Saved in:
Bibliographic Details
Published in:International journal of speech language pathology 2012-10, Vol.14 (5), p.443-446
Main Author: Logemann, Jeri A.
Format: Article
Language:English
Subjects:
dysphagia
Humans
Language Disorders - therapy
Language Therapy - methods
randomized clinical trials
Speech Disorders - therapy
Speech Therapy - methods
Speech-Language Pathology - methods
Swallowing
videofluoroscopy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract This manuscript reviews the current state of research on treatment efficacy for swallowing disorders in relation to the use of large-scale randomized multi institutional trials. Dose response trials, i.e., how much treatment is needed to achieve the desired result, are not yet available in dysphagia. The financial and medical pressures on clinicians responsible for diagnosing and treating the dysphagic patient are noted as they often impact the timing of patient care in dysphagia. The process of integration of treatment techniques into the diagnostic study (Modified Barium Swallow, videofluoroscopy) to improve the patient's swallow as quickly as possible is described. The availability of a clinical trial group, the Communications Sciences and Disorders Clinical Trials Research Group (CSDRG), is noted to assist clinicians and scientists in the development of all types of clinical trials in dysphagia.
ISSN:1754-9507
1754-9515
DOI:10.3109/17549507.2012.717966